-transparent.png){kind=logo}
Intense recent effort towards the development of new drug candidates in the macrolide arena has resulted in the emergence of a number of novel chemical entities; two of these, ABT-773 and HMR-3647, are currently at the advanced clinical trial stage. This review covers the various approaches described in the literature specifically for the synthesis of the ketolide class of compounds.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
J E Resek, and
X C Wang, and
A V Bhatia
September 2000,
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
J E Resek, and
X C Wang, and
A V Bhatia
March 2005,
Bioorganic & medicinal chemistry letters,
J E Resek, and
X C Wang, and
A V Bhatia
September 1964,
Science (New York, N.Y.),
J E Resek, and
X C Wang, and
A V Bhatia
May 2012,
Alzheimer's research & therapy,
J E Resek, and
X C Wang, and
A V Bhatia
July 2012,
Reproductive toxicology (Elmsford, N.Y.),
J E Resek, and
X C Wang, and
A V Bhatia
March 2017,
The Journal of investigative dermatology,
J E Resek, and
X C Wang, and
A V Bhatia
January 2006,
Annals of vascular surgery,
J E Resek, and
X C Wang, and
A V Bhatia
September 2007,
Bioorganic & medicinal chemistry letters,
J E Resek, and
X C Wang, and
A V Bhatia
January 2017,
Developmental period medicine,
J E Resek, and
X C Wang, and
A V Bhatia
February 2019,
Cardiovascular research,
